Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa

Nephrology

Volumn 12, Issue 5, 2007, Pages 448-451

  Walker, Rowan ^a   Pussell, Bruce A ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Darbepoetin alfa; Epoetin alfa; Erythropoietin; Haemodialysis

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENETIC VARIABILITY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING;

AGED; ANALYSIS OF VARIANCE; DATABASES, FACTUAL; EPOETIN ALFA; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RENAL DIALYSIS;

EID: 34548393608     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00802.x     Document Type: Article

References (10)

1. Fishbane S, Berns J. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int. 2005 68 : 1337 43.
2. Bannister KM, Snelling P. National haemodialysis guidelines: An assessment of compliance from 2001 to 2003. Nephrology 2006 11 : 90 6.
3. Pollock C, Barratt L, Saltissi D et al. In: The CARI Guidelines. Knight J, Vimalachandra D (eds). Biochemical and haematological targets. Haemoglobin. Guideline 8, p. 27. Excerpta Medica Communications, Chatswood 2000.
4. National Kidney Foundation. NKF-DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000. Am. J. Kidney Dis. 2001 37 : S182 238.
5. Macdougall IC. Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations. Nephrol. Dial. Transplant. 2002 17 : 66 70.
6. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol. Dial. Transplant. 2001 16 : 3 13.
7. Jamal NM, Krzyzanski W, Cheung W, Lau CY, Messner HA. Evaluation of epoetin alpha (rHuEPO) and darbepoetin alpha (DARB) on human burst-colony formation (BFU-E) in culture. J. Int. Med. Res. 2006 34 : 42 51.
8. Papatheofanis FJ, McKenzie RS, Mody SH, Suruki RY, Piech CT. Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia. Curr. Med. Res. Opin. 2006 22 : 837 42.
9. Excell L, Marshall M, McDonald S. Haemodialysis p36. ANZDATA Registry Report. Adelaide, SA : Australia and New Zealand Dialysis and Transplant Registry, 2004.
10. Johnson S, Byrne P. The technology behind the improvement in anaemia management. J. Renal Care [published 2006; cited Apr 2007] http://www.edtnaerca. org/pages/education/jrc/past/index.php